Multiple Myeloma Research Foundation

Recent papers from Multiple Myeloma Research Foundation

1. Quantitative diffusion and perfusion MRI for non-invasive MYD88/CD79B genotype characterization and prognostic stratification in primary CNS lymphomaCancer Imaging · 2026
2. African Genetic Similarity Is Associated with Reduced Inflammation and Enhanced Adaptive Immunity in Multiple MyelomaBlood · 2026
3. MyeGPT: an AI agent for multiple myelomaBMC Medical Informatics and Decision Making · 2026
4. Adaptive versus fixed designs in confirmatory clinical trials: centering the choice on ethicsClinical Trials · 2026
5. A systematic review of indirect treatment comparisons among recently approved chimeric antigen receptor T-cell and bispecific antibody therapies for triple-class exposed relapsed/refractory multiple myelomaCurrent Medical Research and Opinion · 2026
6. Abstract 3887: Multiple myeloma risk classification of CoMMpass using Consensus Genomic Staging identifies differences between patients with high and low African genetic ancestry.Cancer Research · 2026
7. Abstract 3498: Improving the utility of the single-cell pediatric cancer atlas through updated cell type annotations, CNV inference, and visualization toolsCancer Research · 2026
8. Abstract 5504: CoMMpass Explorer: An interactive platform to explore clinical and genomic data from newly diagnosed multiple myeloma patients from the landmark CoMMpass observational study.Cancer Research · 2026
9. Real-world healthcare resource utilization and clinical outcomes among patients with relapsed/refractory multiple myeloma receiving ciltacabtagene autoleucel after four or more prior lines of therapy in inpatient versus outpatient settingsJournal of Medical Economics · 2026
10. Metabolite biomarkers present in urine predict alterations in skeletal muscle associated with sarcopeniaFrontiers in Aging · 2026
11. A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myelomaNature Cancer · 2026
12. Longitudinal profiling of tumor and immune compartments uncovers patterns of dysregulation and associations with response in multiple myelomaBlood Cancer Discovery · 2025
13. Daratumumab-based quadruplet therapy in functional high-risk relapse/refractory multiple myeloma patients induces changes associated with CD8 T cell signaling, activation and expansionBlood · 2025
14. Combinations of high risk cytogenetic events in multiple myeloma drive distinct immune remodeling patterns and worse outcomesBlood · 2025
15. Evaluating positive behavioral change in multiple myeloma: An MMRF longitudinal study.JCO Oncology Practice · 2025
16. Financial Toxicity and Satisfaction With Cancer Treatment Among Patients With Multiple Myeloma: An Analysis of the MMRF’s CureCloud InitiativeClinical Lymphoma Myeloma & Leukemia · 2025
17. Supporting myeloma patients: Behavioral and emotional outcomes of a navigation program.JCO Oncology Practice · 2025
18. Structure-Guided Design of a Bioactive Covalent Small Molecule Targeting a RiboswitchJournal of the American Chemical Society · 2025
19. Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma.2025
20. BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion studyLeukemia & lymphoma/Leukemia and lymphoma · 2025